Cannabis Poland SA
WSE:CBD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.3315
0.729
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cannabis Poland SA
Accounts Payable
Cannabis Poland SA
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cannabis Poland SA
WSE:CBD
|
Accounts Payable
zł231.9k
|
CAGR 3-Years
57%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
M
|
Molecure SA
WSE:MOC
|
Accounts Payable
zł3m
|
CAGR 3-Years
55%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
C
|
Celon Pharma SA
WSE:CLN
|
Accounts Payable
zł15.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Cannabis Poland SA
Glance View
Cannabis Poland SA engages in the production and distribution of cannabinoid vaporization equipment and oils. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2013-04-09. The firm focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The firm also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The firm is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.
See Also
What is Cannabis Poland SA's Accounts Payable?
Accounts Payable
231.9k
PLN
Based on the financial report for Dec 31, 2023, Cannabis Poland SA's Accounts Payable amounts to 231.9k PLN.
What is Cannabis Poland SA's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
42%
Over the last year, the Accounts Payable growth was 32%. The average annual Accounts Payable growth rates for Cannabis Poland SA have been 57% over the past three years , 42% over the past five years .
You don't have any saved screeners yet
